Princeton, NJ, United States of America

Alexei Guennadievich Tsekoun




Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 95(Granted Patents)


Company Filing History:


Years Active: 2008-2015

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Alexei Guennadievich Tsekoun: Innovator in Analyte Detection Technologies

Introduction

Alexei Guennadievich Tsekoun is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of analyte detection, holding a total of 3 patents. His work focuses on innovative methods and devices that enhance the detection of analytes in bodily fluids.

Latest Patents

Tsekoun's latest patents include advanced arrangements for the detection of the presence and/or concentration of an analyte in a sample of bodily fluid. These arrangements utilize diffuse transmission, diffuse reflection, and edge or waveguide illumination techniques. Additionally, he has developed a vertical flow assay arrangement that features a detection component, which can be an array of optical detection elements. His patents also describe various assay pad constructions that may incorporate components such as prefilter, reflective, membrane, reagent, mesh, and lateral spreading prevention elements.

Career Highlights

Alexei Tsekoun is currently associated with Intuity Medical, Inc., where he continues to innovate in the field of medical diagnostics. His expertise in analyte detection technologies has positioned him as a key player in the industry.

Collaborations

Throughout his career, Tsekoun has collaborated with talented individuals such as Peter John Zanzucchi and Sterling Eduard McBride. These collaborations have further enriched his work and contributed to the development of cutting-edge technologies.

Conclusion

Alexei Guennadievich Tsekoun is a distinguished inventor whose work in analyte detection technologies has made a significant impact in the medical field. His innovative patents and collaborations highlight his commitment to advancing diagnostic methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…